Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 32.67
(0.28%)
CNY 32.67
(0.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 131.38 Million | 703.21 Million | 908.12 Million | 446.06 Million | 25.66 Million | 21.16 Million |
| Net Income | 105.29 Million | 773.58 Million | 835.75 Million | 434.96 Million | 27.93 Million | 18.85 Million |
| Depreciation & Amortization | 29.17 Million | 23.25 Million | 10.53 Million | 5.48 Million | 4.94 Million | 4.15 Million |
| Deferred income taxes | -1.73 Million | -9 Million | -1.48 Million | -429 Thousand | -92.3 Thousand | -10.2 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -49.87 Million | -49.04 Million | 31.32 Million | -22.99 Million | -10.33 Million | -9.29 Million |
| Other non-cash items | -12.21 Million | -44.57 Million | 30.51 Million | 28.6 Million | 3.11 Million | 7.45 Million |
| Investing Cash Flow | 74.36 Million | 96.71 Million | -599.97 Million | -56.07 Million | -39.47 Million | -12.61 Million |
| Investments in PPE | -56.42 Million | -178.91 Million | -200.19 Million | -57.68 Million | -39.47 Million | -12.66 Million |
| Acquisitions | 182.48 Thousand | -0.06 | 399.77 Million | 1.53 Million | - | 54.59 Thousand |
| Investment purchases | -3.8 Million | -290 Million | -400 Million | -50 Million | - | - |
| Sales/Maturities of investments | 134.4 Million | 565.63 Million | 227.21 Thousand | 50.12 Million | - | - |
| Other Investing Activities | 130.78 Million | 275.63 Million | -399.77 Million | -60.66 Thousand | -39.47 Million | 54.59 Thousand |
| Financing Cash Flow | -249.18 Million | -332.65 Million | 813.23 Million | -124.92 Million | 10.93 Million | -1 Million |
| Debt repayment | -239.73 Thousand | -5.28 Million | -11 Million | -46.63 Million | -20 Million | -20.04 Million |
| Dividends payments | -234.66 Million | -320 Million | -20.91 Million | -100.38 Million | -1.08 Million | -883.15 Thousand |
| Common Stock Repurchased | -14.76 Million | - | -856.14 Million | - | - | - |
| Common Stock Issuance | - | - | 856.14 Million | - | - | - |
| Other Financing Activities | -14.76 Million | -7.35 Million | 845.14 Million | 22.09 Million | 32.01 Million | 19.92 Million |
| Accounts receivables | -13.56 Million | 107.83 Million | -51.4 Million | -69.61 Million | -14.41 Million | -7.64 Million |
| Accounts payables | -20.42 Million | -98.94 Million | 145.05 Million | 107.94 Million | 7.89 Million | 9.69 Million |
| Inventory | -14.14 Million | -48.93 Million | -60.84 Million | -60.89 Million | -3.71 Million | -11.33 Million |
| Other working capital | 2.46 Million | -9 Million | -1.48 Million | -429.07 Thousand | -92.31 Thousand | 2.03 Million |
| Cash at beginning of period | 1.93 Billion | 1.36 Billion | 261.04 Million | 13.68 Million | 16.21 Million | 8.77 Million |
| Cash at end of period | 1.9 Billion | 1.93 Billion | 1.36 Billion | 261.04 Million | 13.68 Million | 16.21 Million |
| Capital Expenditure | -56.42 Million | -178.91 Million | -200.19 Million | -57.68 Million | -39.47 Million | -12.66 Million |
| Effect of forex changes on cash | 10.89 Million | 104.9 Million | -14.82 Million | -17.7 Million | 339.88 Thousand | -117.57 Thousand |
| Net cash flow / Change in cash | -32.55 Million | 572.17 Million | 1.1 Billion | 247.36 Million | -2.52 Million | 7.43 Million |
| Free Cash Flow | 74.95 Million | 524.29 Million | 707.92 Million | 388.38 Million | -13.8 Million | 8.5 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 17.03 Million | 32.54 Million | 39.63 Million | 105.29 Million | 19.73 Million | 29.92 Million |
| Depreciation & Amortization | - | 8.12 Million | 8.12 Million | 29.17 Million | 29.17 Million | -14.25 Million |
| Deferred income taxes | - | - | - | -1.73 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 43.63 Million | - | -49.87 Million | -25.24 Million | 19.33 Million |
| Other non-cash items | 3.47 Million | 13.16 Million | 16.89 Million | -12.21 Million | -19.73 Million | 20.49 Million |
| Investing Cash Flow | -2.25 Million | -113.65 Million | -158.16 Million | 74.36 Million | -32.64 Million | 15.32 Million |
| Investments in PPE | -50.42 Million | -13.65 Million | -168.18 Million | -56.42 Million | -42.98 Million | -1.76 Million |
| Acquisitions | - | - | - | 182.48 Thousand | -3.99 Million | -0.48 |
| Investment purchases | -2.37 Billion | -1.27 Billion | - | -3.8 Million | 3850.52 | -3.3 Million |
| Sales/Maturities of investments | 2.42 Billion | 1.17 Billion | 10.01 Million | 134.4 Million | 10.15 Million | 20.38 Million |
| Other Investing Activities | 48.17 Million | -98.52 Million | 10.01 Million | 130.78 Million | 10.34 Million | - |
| Financing Cash Flow | 41.16 Million | -127.68 Million | -40.67 Million | -249.18 Million | -12.44 Million | -13.79 Million |
| Debt repayment | -223.41 Thousand | -66.32 Thousand | - | -239.73 Thousand | -408.95 Thousand | -372.05 Thousand |
| Dividends payments | - | -81.93 Million | - | -234.66 Million | -234.66 Million | -8.69 Million |
| Common Stock Repurchased | 85 Million | -85 Million | - | -14.76 Million | -14.76 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -43.83 Million | -41.25 Million | -40.67 Million | -14.76 Million | -12.85 Million | -4.73 Million |
| Accounts receivables | - | 27.89 Million | - | -13.56 Million | -13.56 Million | 28.45 Million |
| Accounts payables | - | - | - | -20.42 Million | - | 2.9 Million |
| Inventory | - | 13.28 Million | - | -14.14 Million | -14.14 Million | -9.11 Million |
| Other working capital | - | 2.44 Million | - | 2.46 Million | 2.46 Million | -2.9 Million |
| Cash at beginning of period | 1.56 Billion | 1.76 Billion | 1.9 Billion | 1.93 Billion | 1.86 Billion | 1.81 Billion |
| Cash at end of period | 1.61 Billion | 1.56 Billion | 1.76 Billion | 1.9 Billion | 1.9 Billion | 1.86 Billion |
| Capital Expenditure | -50.42 Million | -13.65 Million | -168.18 Million | -56.42 Million | -42.98 Million | -1.76 Million |
| Effect of forex changes on cash | - | 3.44 Million | 793.77 Thousand | 10.89 Million | -8.19 Million | -3.99 Million |
| Net cash flow / Change in cash | 44.48 Million | -200.3 Million | -141.52 Million | -32.55 Million | 41.61 Million | 53.03 Million |
| Free Cash Flow | -29.92 Million | 23.91 Million | -111.65 Million | 74.95 Million | 51.9 Million | 53.74 Million |
PHRRF
NSRCF
SHOORA
DOC
BEC
APCOTEXIND